Skip to main content
. 2018 Nov 17;2018(4):hoy020. doi: 10.1093/hropen/hoy020

Figure 1.

Figure 1

Analysis of leiomyoma driver mutations reveals MED12 mutations and FH inactivation in adenomyomas. Two adenomyomas (Patients 2 and 3) display mediator complex subunit 12 (MED12) mutations (c.131 G > A, p.G44D) and one (Patient 1) shows 2SC positivity indicating fumarate hydratase (FH) inactivation. HE: haematoxylin-eosin staining, HMGA2: high mobility group AT-hook, 2SC: a robust indirect method to detect FH inactivation. Image magnification 40×, scale bar 50 μm.